<p>Managing patients with Parkinson’s disease (PD) involves varied treatments, although the progressive nature of PD and the side effects associated with long-term use of these medications present ongoing challenges. This case report involves an elderly patient with PD who developed gradual asymptomatic hyponatremia after starting Carbidopa-Levodopa. Their sodium levels, initially stable, declined significantly over several months. The patient’s sodium levels improved to pre-treatment levels with fluid restriction and increased protein intake without interruption in Carbidopa-levodopa therapy. This case highlights the need for regular monitoring of sodium levels in PD patients on dopaminergic medications with timely and multidisciplinary strategies to prevent potentially serious complications. </p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Monitoring and management of carbidopa-levodopa-induced hyponatremia in Parkinson’s disease: a case report

  • Elizabeth Schumacher,
  • Nora Abdul-Aziz,
  • Mani Askari,
  • Hoda Shabpiray,
  • Amin Moghaddam

摘要

Managing patients with Parkinson’s disease (PD) involves varied treatments, although the progressive nature of PD and the side effects associated with long-term use of these medications present ongoing challenges. This case report involves an elderly patient with PD who developed gradual asymptomatic hyponatremia after starting Carbidopa-Levodopa. Their sodium levels, initially stable, declined significantly over several months. The patient’s sodium levels improved to pre-treatment levels with fluid restriction and increased protein intake without interruption in Carbidopa-levodopa therapy. This case highlights the need for regular monitoring of sodium levels in PD patients on dopaminergic medications with timely and multidisciplinary strategies to prevent potentially serious complications.